KP
Kala Pharmaceuticals Inc
🇩🇪XBER.27F0GermanyHealthcare
€0.22EURunchanged 0.00 (0%)ClosedEnd of day11:19 PM
Price€0.220.00 (0%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Berlin Stock Exchange . XBER
- Type
- Stock
- ISIN
- US4831192020
- CUSIP
- Not reported
Company
- Employees
- 6
- Headquarters
- Arlington, United States
- Website
- https://www.kalarx.com
- CEO
- Mr. Avi Minkowitz
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$10.08M+72.92%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$19.85M+23.37%up year on year
Other listings
- XFRA.27F0Frankfurt Stock Exchange
- XSTU.27F0Stuttgart Stock Exchange
- XMUN.27F0Munich Stock Exchange
- XDUS.27F0Düsseldorf Stock Exchange
- XNAS.KALANasdaq
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.